Tara Bancroft
Stock Analyst at TD Cowen
(2.85)
# 1,665
Out of 4,784 analysts
8
Total ratings
66.67%
Success rate
29.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TGTX TG Therapeutics | Initiates: Buy | $50 | $39.86 | +25.44% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $48.88 | +32.98% | 1 | Sep 24, 2024 | |
| OCUL Ocular Therapeutix | Upgrades: Buy | $7 → $11 | $7.58 | +45.12% | 3 | Jun 20, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.65 | +506.06% | 1 | Apr 29, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $44.61 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $8.97 | - | 1 | Aug 31, 2022 |
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $39.86
Upside: +25.44%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $48.88
Upside: +32.98%
Ocular Therapeutix
Jun 20, 2024
Upgrades: Buy
Price Target: $7 → $11
Current: $7.58
Upside: +45.12%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.65
Upside: +506.06%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $44.61
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $8.97
Upside: -